The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …

Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and
recommendations, almost on a daily basis. It behooves the medical community to provide …

The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge
for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we …

Patients with chronic diseases have experienced substantial changes to the routine
management of their conditions during the coronavirus disease 2019 (COVID-19) pandemic …

The outbreak of the COVID-19 caused by coronavirus SARS-CoV2, is rapidly spreading
worldwide. This is the first pandemic caused by a coronavirus in history. More than 150 000 …

Background and Aims. The impact of COVID‐19 has been of great concern in patients with
inflammatory bowel disease (IBD) worldwide, including an increased risk of severe …

The purpose of this American Gastroenterological Association (AGA) Institute Clinical
Practice Update was to rapidly review the emerging evidence and provide timely expert …

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems
globally. Early insights have been made possible by rapid sharing of data from China and …

Abstract Background and Aims As no population-based study has investigated the
susceptibility and disease course of COVID-19 among patients with inflammatory bowel …

Objective Our aim was to explore the risk of infection with all classes of inflammatory bowel
disease (IBD) medications and the impact of these medications on the disease course in a …